Invesco S&P Emerging Markets Low Volatility Index ETF (TSE:ELV – Get Free Report) was upgraded by analysts at Raymond James to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.
Separately, Alliance Global Partners raised Invesco S&P Emerging Markets Low Volatility Index ETF to a “strong-buy” rating in a research note on Thursday, September 26th.
Invesco S&P Emerging Markets Low Volatility Index ETF Stock Performance
About Invesco S&P Emerging Markets Low Volatility Index ETF
Elevance Health Inc operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.
Featured Articles
- Five stocks we like better than Invesco S&P Emerging Markets Low Volatility Index ETF
- Technology Stocks Explained: Here’s What to Know About Tech
- Procter & Gamble Proves It’s No Gamble: Uptrend Remains Strong
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Should You Buy the Oil Dip? Top Energy Stocks to Hold Now
- Ride Out The Recession With These Dividend Kings
- Market Momentum: 3 Stocks Poised for Significant Breakouts
Receive News & Ratings for Invesco S&P Emerging Markets Low Volatility Index ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco S&P Emerging Markets Low Volatility Index ETF and related companies with MarketBeat.com's FREE daily email newsletter.
